Trials / Terminated
TerminatedNCT03706430
Validation of RPVi as a Parameter to Predict Fluid Responsiveness
- Status
- Terminated
- Phase
- —
- Study type
- Interventional
- Enrollment
- 63 (actual)
- Sponsor
- Masimo Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, nonrandomized, sequential data collection study to evaluate the ability of RPVi to predict fluid responsiveness in comparison with other dynamic parameters including stroke volume variation (SVV) and/or pulse pressure variation (PPV).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Pulse CO-Oximeter sensor | Investigational Pulse CO-Oximeter sensor will measure hemoglobin (SpHb), Pulse Rate (PR), Perfusion Index (Pi), Methemoglobin (SpMet), Pleth Variability Index (PVi), RPVi, etc. |
Timeline
- Start date
- 2018-09-24
- Primary completion
- 2021-10-20
- Completion
- 2021-10-20
- First posted
- 2018-10-16
- Last updated
- 2025-11-13
- Results posted
- 2023-06-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03706430. Inclusion in this directory is not an endorsement.